Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Warfarin pharmacogenetics meets clinical use.

Schwab M, Schaeffeler E.

Blood. 2011 Sep 15;118(11):2938-9. doi: 10.1182/blood-2011-07-367763. No abstract available.

PMID:
21921056
[PubMed - indexed for MEDLINE]
Free Article
2.

Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy.

Gong IY, Tirona RG, Schwarz UI, Crown N, Dresser GK, Larue S, Langlois N, Lazo-Langner A, Zou G, Roden DM, Stein CM, Rodger M, Carrier M, Forgie M, Wells PS, Kim RB.

Blood. 2011 Sep 15;118(11):3163-71. doi: 10.1182/blood-2011-03-345173. Epub 2011 Jul 1.

PMID:
21725053
[PubMed - indexed for MEDLINE]
Free Article
3.

Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements.

Gage BF, Milligan PE.

Thromb Res. 2005;117(1-2):55-9; discussion 65-7. Epub 2005 Jul 25. Review. No abstract available.

PMID:
16043212
[PubMed - indexed for MEDLINE]
4.

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.

Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, Maloney W, Clohisy J, Burnett RS, Grosso L, Gatchel SK, Gage BF.

Thromb Haemost. 2005 Apr;93(4):700-5.

PMID:
15841315
[PubMed - indexed for MEDLINE]
5.

The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - a decision analysis.

You JH, Chan FW, Wong RS, Cheng G.

Thromb Haemost. 2004 Sep;92(3):590-7.

PMID:
15351856
[PubMed - indexed for MEDLINE]
6.

Gene-based warfaring dosing.

Carleton B.

Ther Drug Monit. 2010 Jun;32(3):332. doi: 10.1097/FTD.0b013e3181e1a665. No abstract available.

PMID:
20498559
[PubMed - indexed for MEDLINE]
7.

Use of pharmacogenetics to guide warfarin therapy.

Voora D, McLeod HL, Eby C, Gage BF.

Drugs Today (Barc). 2004 Mar;40(3):247-57.

PMID:
15148533
[PubMed - indexed for MEDLINE]
8.

Pharmacogenomics and warfarin.

Anderson DC Jr.

Am J Health Syst Pharm. 2009 Jan 15;66(2):121. doi: 10.2146/ajhp080635. No abstract available.

PMID:
19139475
[PubMed - indexed for MEDLINE]
9.

Warfarin pharmacogenetics: ready for clinical utility?

Baudhuin LM.

Clin Lab Sci. 2009 Summer;22(3):151-5. No abstract available.

PMID:
19827409
[PubMed - indexed for MEDLINE]
10.

Warfarin dose prediction in children using pharmacogenetics information.

Biss T, Hamberg AK, Avery P, Wadelius M, Kamali F.

Br J Haematol. 2012 Oct;159(1):106-9. doi: 10.1111/j.1365-2141.2012.09230.x. Epub 2012 Jul 18. No abstract available.

PMID:
22804567
[PubMed - indexed for MEDLINE]
11.

Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing.

Roper N, Storer B, Bona R, Fang M.

J Mol Diagn. 2010 May;12(3):283-91. doi: 10.2353/jmoldx.2010.090110. Epub 2010 Mar 12.

PMID:
20228265
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL.

Thromb Haemost. 2004 Jan;91(1):87-94.

PMID:
14691573
[PubMed - indexed for MEDLINE]
13.

Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.

Grice GR, Milligan PE, Eby C, Gage BF.

J Thromb Haemost. 2008 Jan;6(1):207-9. Epub 2007 Oct 12. No abstract available.

PMID:
17944998
[PubMed - indexed for MEDLINE]
14.

Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.

Takahashi H, Echizen H.

Pharmacogenomics J. 2003;3(4):202-14. Review. No abstract available.

PMID:
12931134
[PubMed - indexed for MEDLINE]
15.

Exploring warfarin pharmacogenomics with the extreme-discordant-phenotype methodology: impact of FVII polymorphisms on stable anticoagulation with warfarin.

Fuchshuber-Moraes M, Perini JA, Rosskopf D, Suarez-Kurtz G.

Eur J Clin Pharmacol. 2009 Aug;65(8):789-93. doi: 10.1007/s00228-009-0651-6. Epub 2009 Apr 23.

PMID:
19387626
[PubMed - indexed for MEDLINE]
16.

PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.

Owen RP, Altman RB, Klein TE.

Hum Mutat. 2008 Apr;29(4):456-60. doi: 10.1002/humu.20731.

PMID:
18330919
[PubMed - indexed for MEDLINE]
17.

Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients.

Hatch E, Wynne H, Avery P, Wadelius M, Kamali F.

J Thromb Haemost. 2008 Jun;6(6):1038-40. doi: 10.1111/j.1538-7836.2008.02974.x. Epub 2008 Apr 14. No abstract available.

PMID:
18419746
[PubMed - indexed for MEDLINE]
18.

Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients.

Choi JR, Kim JO, Kang DR, Yoon SA, Shin JY, Zhang X, Roh MO, Hong HJ, Wang YP, Jo KH, Lee KS, Yun HJ, Oh YS, Yoo KD, Jeon HG, Lee YS, Kang TS, Park HJ, Chung MW, Kang JH.

J Hum Genet. 2011 Apr;56(4):290-5. doi: 10.1038/jhg.2011.4. Epub 2011 Feb 17.

PMID:
21326313
[PubMed - indexed for MEDLINE]
19.

Overview of pharmacogenetics in anticoagulation therapy.

Hill CE, Duncan A.

Clin Lab Med. 2008 Dec;28(4):513-24. doi: 10.1016/j.cll.2008.09.002. Review.

PMID:
19059059
[PubMed - indexed for MEDLINE]
20.

Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.

George J, Doney A, Palmer CN, Lang CC.

Cardiovasc Ther. 2010 Jun;28(3):135-8. doi: 10.1111/j.1755-5922.2010.00176.x. No abstract available.

PMID:
20557312
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk